Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 4:00 PM ET

Date/Time Source News Release
06/11/2025 08:00 AM EDT GlobeNewswire Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
06/05/2025 08:00 AM EDT GlobeNewswire Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
05/13/2025 04:28 PM EDT GlobeNewswire Tempest Reports First Quarter 2025 Financial Results and Provides Business Update
04/28/2025 04:05 PM EDT GlobeNewswire Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
04/21/2025 08:00 AM EDT GlobeNewswire Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
04/09/2025 04:30 PM EDT GlobeNewswire Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value
03/27/2025 04:10 PM EDT GlobeNewswire Tempest Reports Year End 2024 Financial Results and Provides Business Update
03/25/2025 04:30 PM EDT GlobeNewswire Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
03/13/2025 08:00 AM EDT GlobeNewswire FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)
02/10/2025 08:00 AM EST GlobeNewswire Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Page

Additional News

As of June 14, 2025 • 4:00 PM ET

Date/Time Source News Release
06/12/2025 09:05 AM EDT USA News Group After Major Oncology Conference, All Eyes Turn to Industry Innovation
06/11/2025 08:31 AM EDT SeekingAlpha Tempest announces $4.6 million registered direct offering of common stock; shares decline over 13%
06/06/2025 11:35 AM EDT Zacks TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy
05/13/2025 05:16 PM EDT SeekingAlpha Tempest Therapeutics GAAP EPS of -$3.16 misses by $0.01
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Tempest Therapeutics Inc.
04/10/2025 11:05 AM EDT Zacks TPST to Evaluate Strategic Options for Pipeline Studies, Stock Up
04/09/2025 09:01 AM EDT KlickAnalytics TPST announced stock split 1-13
03/27/2025 04:52 PM EDT SeekingAlpha Tempest Therapeutics GAAP EPS of -$1.50 misses by $0.15
03/25/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 25th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.